Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Comment
. 2023 Mar 30;74(1):92-94.
doi: 10.18597/rcog.4015.

Reply to: “Comments on the article entitled “Primary ADN-VPH screening in women under 30 years of age: health technology assessment”

[Article in English, Spanish]
Carmen Doris Garzón-Olivares  1 , Carlos Fernando Grillo-Ardila  2 , Jairo Amaya-Guío  3
Affiliations
Comment

Reply to: “Comments on the article entitled “Primary ADN-VPH screening in women under 30 years of age: health technology assessment”

[Article in English, Spanish]
Carmen Doris Garzón-Olivares et al. Rev Colomb Obstet Ginecol. .
No abstract available

PubMed Disclaimer

Conflict of interest statement

Conflicto de intereses: los autores declaran no tener conflictos de interés.

Comment on

Similar articles

See all similar articles

References

    1. Ferlay J, Ervik M, Lam F, Colombet M, Mery L, Piñeros M, et al. Global Cancer Observatory: Cancer Today. Lyon, France: International Agency for Research on Cancer; 2020. https://gco.iarc.fr/today
    1. Peirson L, Fitzpatrick D, Ciliska D, Warren R. Screening for cervical cancer: a systematic review and meta-analysis. Syst Rev. 2013;2(35) doi: 10.1186/2046-4053-2-35. - DOI - PMC - PubMed
    1. Ronco G, Dillner J, Elfstrom KM, Tunesi S, Snijders PJ, Arbyn M, et al. Efficacy of HPV-based screening for prevention of invasive cervical cancer: followup of four European randomised controlled trials. Lancet. 2014;383:524–532. doi: 10.1016/S0140-6736(13)62218-7. - DOI - PubMed
    1. Hashim D, Engesæter B, Baadstrand G, Castle PE, Bjørge T, Tropé A, et al. Real-world data on cervical cancer risk stratification by cytology and HPV genotype to inform the management of HPV-positive women in routine cervical screening. Br J Cancer. 2020;122(11):1715–1723. doi: 10.1038/s41416-020-0790-1. - DOI - PMC - PubMed
    1. Gupta R, Sharda A, Kumar D, Fulzele R, Dwivedi R, Gupta S. Cervical Cancer Screening: Is the Age Group 30-65 Years Optimum for Screening in Low-Resource Settings? J Obstet Gynaecol India. 2021;71(5):530–536. doi: 10.1007/s13224-021-01479-w. - DOI - PMC - PubMed